Dhan Chand
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Dhan Chand
Sep 14, 2024, 09:43 |
Insight
Article of the day, September 14th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 10, 2024, 13:39 |
Insight
Botensilimab’s effectiveness against tumours poorly responsive to conventional immunotherapy
Justin Stebbing shared a post on LinkedIn: “Congratulations to Dhan Chand and the Agenus team…
Jun 28, 2024, 15:58 |
Insight
Updates on BOT/BAL from ESMOGI24
ESMO GI 2024 is held in Munich, Germany, and online from June 26-29. Organized by…
Jun 28, 2024, 13:48 |
Insight
Arndt Vogel: Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at ESMOGI24
Arndt Vogel shared on X: "Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at…
Jun 28, 2024, 13:41 |
Insight
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Agenus shared on their X page: "New data from the NEST clinical trial was presented…
Jun 16, 2024, 02:00 |
Blog
Justin Stebbing: Activity of botensilimab/balstilimab in patients with metastatic colon cancer
Justin Stebbing shared a post on LinkedIn: "Really interesting paper out today am part of in…
Jun 14, 2024, 01:23 |
Insight
New Paper Alert! Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab
Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab Authors: Andrea J. Bullock,…
Jun 13, 2024, 17:33 |
Insight
Agenus' Phase 1 clinical trial results have been published in Nature
Agenus shared their publication on investigational immunotherapeutic agents in Nature: "Results from our Phase 1…
Apr 9, 2024, 15:56 |
Blog
We’ve been energized and inspired by our time at AACR2024 - Agenus
Agenus shared a post on LinkedIn: “We’ve been energized and inspired by our time at AACR2024.…
Jan 9, 2024, 08:50 |
Blog
Prominent cancer specialists and emerging leaders in the field of oncology join the Editorial Board of OncoDaily
OncoDaily welcomes world-renowned cancer specialists and emerging leaders in oncology. We are honored to have…
Nov 17, 2023, 13:59 |
Insight
Revolutionizing Cancer Immunotherapy: Next-Gen CTLA-4 Targeting and Combination Therapies
Dive into the groundbreaking research published in "Oncology Immunology" (2023), where leading scientists Nils-Petter Rudqvist,…
May 24, 2023, 15:51 |
Positive
A Relentless Pursuit on Behalf of Patients: The Work of Cancer Research
Every May, the American Association for Cancer Research marks National Cancer Research Month #NCRM, committed to raising awareness…
All:
12
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube